Why Investors Should Be Watching Vertex Pharmaceuticals
Vertex Pharmaceuticals is expanding beyond its cystic fibrosis drugs, although the franchise continues to perform very well for the company. In this segment from "This Week in Healthcare," recorded on Jan. 31, Motley Fool contributors Brian Orelli and Keith Speights discuss the new markets that could be highly profitable for Vertex.
Source Fool.com
